- $259.61m
- $298.95m
- $104.85m
- 47
- 76
- 89
- 80
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K/A | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Interest Income | |||||
Interest Expense | |||||
Net Interest Income | 67.8 | 78.3 | 72.8 | 96.7 | 97.9 |
Loan Loss Provision | |||||
Net Interest Income After Loan Loss Provision | 65.6 | 78.3 | 72.3 | 92.3 | 95.9 |
Non Interest Income | |||||
Non Interest Expense | |||||
Net Income Before Taxes | 23.7 | 18.2 | 28.5 | 32.4 | 38.2 |
Provision for Income Taxes | |||||
Net Income After Taxes | 17.3 | 13.7 | 20.7 | 23.7 | 27.4 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 17.3 | 13.7 | 20.7 | 23.7 | 27.4 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 17.3 | 13.7 | 20.7 | 23.7 | 27.4 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.46 | 1.94 | 1.9 | 1.72 | 2.27 |
Dividends per Share |